148 related articles for article (PubMed ID: 23087330)
1. The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.
Pinder SE; Brown JP; Gillett C; Purdie CA; Speirs V; Thompson AM; Shaaban AM;
J Clin Pathol; 2013 Mar; 66(3):169-77. PubMed ID: 23087330
[TBL] [Abstract][Full Text] [Related]
2. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
3. Robust gridding of TMAs after whole-slide imaging using template matching.
Lahrmann B; Halama N; Westphal K; Ernst C; Elsawaf Z; Sinn P; Bosch FX; Dickhaus H; Jäger D; Schirmacher P; Grabe N
Cytometry A; 2010 Dec; 77(12):1169-76. PubMed ID: 20662092
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.
Thomson TA; Zhou C; Chu C; Knight B
Am J Clin Pathol; 2009 Dec; 132(6):899-905. PubMed ID: 19926582
[TBL] [Abstract][Full Text] [Related]
5. Construction of tissue microarrays using pre-existing slides as source of tissue when paraffin blocks are unavailable.
Deng FM; Zhao Y; Kong X; Lee P; Melamed J
J Clin Pathol; 2013 Jul; 66(7):627-9. PubMed ID: 23476078
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarrays: construction and use.
Remotti H
Methods Mol Biol; 2013; 980():13-28. PubMed ID: 23359147
[TBL] [Abstract][Full Text] [Related]
7. Application of a novel and low cost technique to construct paraffin tissue microarrays out of paraffinised needle biopsy specimens from patients with breast cancer.
Vogel UF; Bültmann B
J Clin Pathol; 2010 Jul; 63(7):640-3. PubMed ID: 20591915
[TBL] [Abstract][Full Text] [Related]
8. Implementation of TMA and digitalization in routine diagnostics of breast pathology.
Rossing HH; Talman ML; Laenkholm AV; Wielenga VT
APMIS; 2012 Apr; 120(4):341-7. PubMed ID: 22429216
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
Jones S; Prasad ML
Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
Graham AD; Faratian D; Rae F; Thomas JS
Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
[TBL] [Abstract][Full Text] [Related]
11. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
12. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
J Clin Pathol; 2007 Apr; 60(4):397-404. PubMed ID: 16775123
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
Mucci NR; Akdas G; Manely S; Rubin MA
Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
[TBL] [Abstract][Full Text] [Related]
14. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Camp RL; Neumeister V; Rimm DL
J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
[TBL] [Abstract][Full Text] [Related]
15. Multiple biomarker tissue microarrays: bioinformatics and practical approaches.
Bentzen SM; Buffa FM; Wilson GD
Cancer Metastasis Rev; 2008 Sep; 27(3):481-94. PubMed ID: 18437294
[TBL] [Abstract][Full Text] [Related]
16. The role of tissue microarrays in prostate cancer biomarker discovery.
Datta MW; True LD; Nelson PS; Amin MB
Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
[TBL] [Abstract][Full Text] [Related]
17. Tissue microarrays: construction and uses.
Fowler CB; Man YG; Zhang S; O'Leary TJ; Mason JT; Cunningham RE
Methods Mol Biol; 2011; 724():23-35. PubMed ID: 21370004
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray validation: a methodologic study with special reference to lung cancer.
Karlsson C; Bodin L; Piehl-Aulin K; Karlsson MG
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2014-21. PubMed ID: 19531681
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue microarray in the era of target-based agents.
Franco R; Caraglia M; Facchini G; Abbruzzese A; Botti G
Expert Rev Anticancer Ther; 2011 Jun; 11(6):859-69. PubMed ID: 21707283
[TBL] [Abstract][Full Text] [Related]
20. Use and validation of epithelial recognition and fields of view algorithms on virtual slides to guide TMA construction.
Barsky S; Gentchev L; Basu A; Jimenez R; Boussaid K; Gholap A
Biotechniques; 2009 Nov; 47(5):927-38. PubMed ID: 20041846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]